3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
5
Colitis
4
Carcinoma, Non-Small-Cell Lung
3
Urogenital Neoplasms
2
Vasculitis
1
Stroke
1
Skin Neoplasms
1
Lung Neoplasms
1
Kidney Transplantation
1
Hepatitis
1
Hematologic Neoplasms
1
Graft vs Host Disease
1
Drug-Related Side Effects and Adverse Reactions
1
Depressive Disorder, Treatment-Resistant
1
Depressive Disorder, Major
1
Depression
1
Colitis, Ulcerative
1
Bronchiolitis Obliterans Syndrome
1
Bipolar Disorder
1
Aneurysm
1
Interventions
tocilizumab
2
siltuximab
2
fludarabine phosphate
2
fludarabine
2
Interleukin 1 Receptor Antagonist Protein
2
Cyclophosphamide
2
AP 1903 reagent
2
talquetamab
1
obinutuzumab
1
glofitamab
1
axicabtagene ciloleucel
1
Oxaliplatin
1
Gemcitabine
1
Dexamethasone
1
Calcium Dobesilate
1
Bendamustine Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cytokine Release Syndrome
×
Infliximab
×
1 year
×
Clear all
No trials found.